Related Experiment Video
Updated: Jan 20, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala
Nicolette Nabukeera-Barungi1, Israel Kalyesubula, Addy Kekitiinwa
1Department of Paediatrics and Child Health, Faculty of Medicine, Makerere University, Kampala, Uganda. nicbarungi@yahoo.com
Insights
Adherence to antiretroviral therapy (ART) in children is crucial for managing HIV/AIDS. Unannounced pill counts revealed good adherence, but limited disclosure of HIV status and prior hospitalizations were linked to non-adherence.
Area of Science:
- Pediatric infectious diseases
- Public health
- HIV/AIDS management
Background:
- Non-adherence to antiretroviral therapy (ART) significantly impacts treatment effectiveness in children with HIV/AIDS.
- The study was conducted at the pediatric HIV/AIDS clinic of Mulago Hospital in Kampala, Uganda.
Purpose of the Study:
- To assess adherence levels to highly active antiretroviral therapy (HAART) among children.
- To identify factors associated with non-adherence to HAART in this pediatric population.
Main Methods:
- A cross-sectional study involving 170 children aged 2-18 years.
- Adherence was defined as taking ≥95% of prescribed medication.
- Multiple assessment methods were used: 3-day caregiver self-report, clinic pill counts, and unannounced home-based pill counts.
Main Results:
- Adherence rates varied by measurement method: 89.4% (self-report), 94.1% (clinic pill count), and 72% (unannounced pill count).
- Limited disclosure of the child's HIV status solely to the primary caregiver was associated with a threefold increased risk of non-adherence (OR 3.34, p=0.02).
- Children with two or more prior hospitalizations before starting HAART showed higher adherence (OR 0.44, p=0.02).
Conclusions:
- Unannounced pill counts indicated that most children achieved good adherence to HAART.
- Factors associated with poor adherence included restricted disclosure of HIV status and fewer prior hospitalizations.
Background:
Non-adherence reduces the effectiveness of antiretroviral therapy in children attending the paediatric HIV/AIDS clinic at Mulago Hospital, Kampala.
Aim:
To determine the levels of adherence to HAART and identify factors associated with non-adherence.
Methods:
A cross-sectional study of 170 children aged 2-18 years. Adherence to HAART was defined as taking > or =95% of prescribed medication. It was determined using three measures: a 3-day self-report by the caregivers, clinic-based pill counts at enrolment and home-based unannounced pill counts 2-3 weeks later.
Results:
The 3-day self-reported > or =95% adherence was 89.4% (n=170). Using clinic-based pill counts, 94.1% (n=170) had > or =95% adherence to treatment compared with only 72% (n=164) by unannounced pill counts. When the primary caregiver was the only one who knew the child's serostatus, he/she was three times more likely to be non-adherent (p=0.02, OR 3.34, 95% CI 1.14-9.82). Those who had been hospitalised twice or more before starting HAART were more likely to have > or =95% adherence (p=0.02, OR 0.44, 95% CI 0.20-0.92).
Conclusion:
The majority of children had good adherence levels when estimated by unannounced pill counts. Disclosing the child's HIV serostatus only to the primary caregiver and having been hospitalised only once or not at all were associated with poor adherence.
Related Concept Videos
Drug Dosing: Infants and Children
Hospitals-II
Nurses that work in...
Hospitals-I
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

